THE PATHOLOGY OF MELANOMA:
AN INTERNATIONAL COURSE
APRIL 11 & 12, 2024
// OBJECTIVE
Following the success of our Courses in 2017, 2018, 2020, and 2022 the objective of the Fourth International Melanoma Course in 2024 will continue a criteria-based approach: “Avoiding Errors in Diagnosis via True Cases”, as well as an update of all cutting-edge knowledge on
difficult melanocytes lesions relevant to practicing pathologists and clinicians.
This 2024 venue will make use of the expertise of the SIRIC (Integrated Cancer Research Site at Institut Curie), WHO 5th Edition Classification of Melanocytic Tumours, the International Melanoma Pathology Study Group, and the latest information concerning the new revised MPATH-Dx schema and related studies.
// THE MPATH MELANOMA PATHOLOGY STUDY DATABASE
- Online access in advance and review of digitized images from extensively-characterized cases constituting the MPath study set.
This unique study set has been reviewed by the MPath Pathology Panel (Prs. Barnhill, Elder, and Piepkorn), and a large diverse group of pathologists. - The Course will be practical and based on the extensive experience of the international faculty participating in the Course. The Course will consist of didactic lectures and interactive sessions during the two-day program.
List of speakers
Directors
Director of the course
Director
Director
Director
Director
PRELIMINARY LIST OF SPEAKERS
Pr Raymond Barnhill,
Institut Curie and University
of Paris Cité, Paris, France,
Director of the Course
Pr Boris Bastian,
University of California
San Francisco, USA
Pr Klaus Busam,
Memorial Sloan Kettering
Cancer Center, New York, USA
Pr David Elder,
University of Pennsylvania,
Philadelphia, USA
Pr Richard Scolyer,
Melanoma Institute of Australia
and the University of Sydney,
Sydney, Australia
Dr Claire Lugassy,
Institut Curie, Paris, France
Dr Alexandre Matet,
Institut Curie and University
of Paris Cité, Paris, France
Dr Denis Malaise,
Institut Curie, Paris, France
Pr Lori Lowe,
University of Michigan, Ann Arbor, USA
Pr Ian Cree,
IARC, Lyon, France
Dr Arnaud de la Fouchardière,
Centre Léon Bérard, Lyon, France
NON EXHAUSTIVE LIST OF TOPICS
- WHO 5th Edition update of melanocytic tumours
- New MPATH-Dx V2.0 Schema
- General approach to the difficult melanocytic lesion
- Congenital nevi and related lesions
- Acquired melanocytic nevi and including unusual and special variants
- Dysplastic nevi
- Spitzoid melanocytic neoplasms
- Blue nevi and atypical variants
- Nevoid melanoma
- Lentigo maligna melanoma
- Desmoplastic melanoma
- Melanoma arising in blue nevus
- Conventional cutaneous melanoma
- Pediatric melanoma
- Acral melanoma
- Mucosal melanoma
- Melanocytic lesions of the nail apparatus
- Conjunctival melanocytic lesions including nevi and melanosis
- Conjunctival melanoma
- Uveal melanoma
- Angiotropic extravascular migratory metastasis
- AJCC guidelines (8th Edition) for cutaneous and ocular melanoma staging
- Practical immunohistochemistry
- Practical molecular analysis of melanocytic lesions
- Immune checkpoint pathways
- The reporting of melanoma and prognostic factors
- What the clinician expects from the pathologist